This study is testing if breathing extra oxygen (Normobaric Oxygen) can help individuals experiencing their first episode of psychosis. Researchers believe that improving oxygen supply to the brain might help with symptoms. You could be eligible if you are between 15 and 35 years old and have been diagnosed with a schizophrenia-spectrum disorder or mood disorder with psychotic features, and have had psychotic symptoms for less than 5 years. The study will look at whether Normobaric Oxygen improves your cognitive functioning (thinking skills), quality of life, and social functioning after 4 weeks. The current status of this study is unclear, and it plans to enroll 20 participants.

Study design

This is a single-blind, randomized controlled trial. This means you won't know if you're receiving the oxygen or a placebo, but the researchers will. It plans to include 20 participants.

What's involved

You would receive either Normobaric Oxygen or a placebo (room air) through a nasal cannula overnight for 4 weeks. After that, everyone will receive Normobaric Oxygen for another 4 weeks. Assessments will be done at the start, after 4 weeks, and after 8 weeks.

Compensation

Not stated in the trial record.

Follow-up

You will be followed for 8 weeks after enrollment, with assessments at 4 and 8 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.